• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干细胞标志物 Oct4A、Nanog 和 c-Myc 在卵巢癌患者的腹水细胞和肿瘤组织中表达。

The stem cell markers Oct4A, Nanog and c-Myc are expressed in ascites cells and tumor tissue of ovarian cancer patients.

机构信息

Department of Tumor Immunology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500HB, Nijmegen, The Netherlands.

出版信息

Cell Oncol (Dordr). 2013 Oct;36(5):363-74. doi: 10.1007/s13402-013-0142-8. Epub 2013 Aug 9.

DOI:10.1007/s13402-013-0142-8
PMID:23928726
Abstract

PURPOSE

The aim of this study was to examine the expression of established stem cell markers in ascites and tumor tissue obtained from ovarian cancer patients.

METHODS

Mononuclear cells present in ascites were collected by density gradient centrifugation. Intracellular flowcytometry was used to assess the putative presence of stem cell markers. RT-PCR was used to detect full length Oct4A, a splice variant Oct4B, implicated in glioma and breast cancer, Oct4 pseudogenes and c-Myc. Genes were cloned and sequenced to determine putative mutations. Confocal laser scanning microscopy was performed to localize the markers in ascites cells as well as in tumor tissue. Material from carcinomas other than epithelial ovarian carcinoma served as control.

RESULTS

A small quantity of cells in ascites and in tumor tissue of ovarian cancer patients was detected that expresses c-Myc, Oct4A and Nanog. Besides Oct4A, present in the nucleus, also the cytoplasmic resident Oct4B splice variant was detected. Remarkably, c-Myc was found partially in the cytoplasm. Since no mutations in c-Myc were found that could explain the cytoplasmic localization, we hypothesize that this is due an IL-6 induced c-Myc shuttle factor.

CONCLUSIONS

The expression of stem cell genes was detected in a small proportion of tumor cells present in ascites as well as in tumor tissue. IL-6 plays an important role in the induction of c-Myc.

摘要

目的

本研究旨在检测从卵巢癌患者的腹水和肿瘤组织中获得的已确立的干细胞标志物的表达。

方法

通过密度梯度离心收集腹水单核细胞。使用细胞内流式细胞术评估干细胞标志物的存在。使用 RT-PCR 检测全长 Oct4A、与神经胶质瘤和乳腺癌相关的剪接变体 Oct4B、Oct4 假基因和 c-Myc。克隆和测序基因以确定可能的突变。使用共聚焦激光扫描显微镜在腹水细胞和肿瘤组织中定位标志物。上皮性卵巢癌以外的癌组织作为对照。

结果

在卵巢癌患者的腹水中和肿瘤组织中检测到少量表达 c-Myc、Oct4A 和 Nanog 的细胞。除了存在于核中的 Oct4A 外,还检测到细胞质驻留的 Oct4B 剪接变体。值得注意的是,c-Myc 部分存在于细胞质中。由于未发现可解释细胞质定位的 c-Myc 突变,我们假设这是由于 IL-6 诱导的 c-Myc 穿梭因子所致。

结论

在腹水和肿瘤组织中存在的少量肿瘤细胞中检测到干细胞基因的表达。IL-6 在诱导 c-Myc 中起重要作用。

相似文献

1
The stem cell markers Oct4A, Nanog and c-Myc are expressed in ascites cells and tumor tissue of ovarian cancer patients.干细胞标志物 Oct4A、Nanog 和 c-Myc 在卵巢癌患者的腹水细胞和肿瘤组织中表达。
Cell Oncol (Dordr). 2013 Oct;36(5):363-74. doi: 10.1007/s13402-013-0142-8. Epub 2013 Aug 9.
2
Induced overexpression of Oct4A in human dental pulp cells enhances pluripotency and multilineage differentiation capability.诱导人牙髓细胞中 Oct4A 的过表达增强了多能性和多谱系分化能力。
Stem Cells Dev. 2015 Apr 15;24(8):962-72. doi: 10.1089/scd.2014.0388. Epub 2015 Jan 8.
3
Protein markers of cancer-associated fibroblasts and tumor-initiating cells reveal subpopulations in freshly isolated ovarian cancer ascites.癌症相关成纤维细胞和肿瘤起始细胞的蛋白标志物揭示了新鲜分离的卵巢癌腹水中的亚群。
BMC Cancer. 2012 Aug 18;12:359. doi: 10.1186/1471-2407-12-359.
4
Subcellular localisation of the stem cell markers OCT4, SOX2, NANOG, KLF4 and c-MYC in cancer: a review.癌症中干细胞标志物OCT4、SOX2、NANOG、KLF4和c-MYC的亚细胞定位:综述
J Clin Pathol. 2018 Jan;71(1):88-91. doi: 10.1136/jclinpath-2017-204815. Epub 2017 Nov 27.
5
Klf4 transcription factor is expressed in the cytoplasm of prostate cancer cells.Klf4 转录因子在前列腺癌细胞的细胞质中表达。
Eur J Cancer. 2013 Mar;49(4):955-63. doi: 10.1016/j.ejca.2012.09.023. Epub 2012 Oct 22.
6
Cell fate determination factor Dachshund reprograms breast cancer stem cell function. Dachshund 细胞命运决定因子重编程乳腺癌干细胞功能。
J Biol Chem. 2011 Jan 21;286(3):2132-42. doi: 10.1074/jbc.M110.148395. Epub 2010 Oct 11.
7
Analysis of Human Stem Cell Transcription Factors.人类干细胞转录因子分析
Cell Reprogram. 2019 Aug;21(4):171-180. doi: 10.1089/cell.2019.0005. Epub 2019 Jul 12.
8
Galectin-3 modulates the EGFR signalling-mediated regulation of Sox2 expression via c-Myc in lung cancer.半乳糖凝集素-3通过c-Myc调节肺癌中表皮生长因子受体信号介导的Sox2表达调控。
Glycobiology. 2016 Feb;26(2):155-65. doi: 10.1093/glycob/cwv088. Epub 2015 Oct 6.
9
Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells.通过下调人乳腺干细胞中八聚体结合蛋白4和Nanog转录因子的表达来降低肿瘤发生能力和耐药性。
Mol Med Rep. 2015 Mar;11(3):1647-54. doi: 10.3892/mmr.2014.2972. Epub 2014 Nov 18.
10
Small putative NANOG, SOX2, and SSEA-4-positive stem cells resembling very small embryonic-like stem cells in sections of ovarian tissue in patients with ovarian cancer.在卵巢癌患者的卵巢组织切片中,存在类似极小胚胎样干细胞的假定NANOG、SOX2和SSEA - 4阳性小干细胞。
J Ovarian Res. 2016 Mar 3;9:12. doi: 10.1186/s13048-016-0221-3.

引用本文的文献

1
Expression of Oct3/4 isoforms and its association with the risk of relapse in acute lymphoblastic leukemia.Oct3/4亚型的表达及其与急性淋巴细胞白血病复发风险的关联。
Biomed Rep. 2025 Aug 12;23(4):164. doi: 10.3892/br.2025.2042. eCollection 2025 Oct.
2
Deciphering Common Traits of Breast and Ovarian Cancer Stem Cells and Possible Therapeutic Approaches.解析乳腺癌和卵巢癌干细胞的共同特征及可能的治疗方法。
Int J Mol Sci. 2023 Jun 26;24(13):10683. doi: 10.3390/ijms241310683.
3
Polyphyllin VII as a Potential Drug for Targeting Stemness in Hepatocellular Cancer STAT3 Signaling.

本文引用的文献

1
Functional OCT4-specific CD4 and CD8 T cells in healthy controls and ovarian cancer patients.健康对照者和卵巢癌患者中功能性OCT4特异性CD4和CD8 T细胞。
Oncoimmunology. 2013 May 1;2(5):e24271. doi: 10.4161/onci.24271. Epub 2013 Apr 1.
2
A molecular beacon-based method for screening cervical cancer.一种基于分子信标的宫颈癌筛查方法。
J Nanosci Nanotechnol. 2012 Nov;12(11):8282-6. doi: 10.1166/jnn.2012.6789.
3
Oxidants, antioxidants and the current incurability of metastatic cancers.氧化剂、抗氧化剂与转移性癌症的当前不可治愈性。
重楼七叶皂苷 VII 作为一种潜在的药物,针对肝癌干细胞的 STAT3 信号通路。
Curr Cancer Drug Targets. 2023;23(4):325-331. doi: 10.2174/1568009623666221024103834.
4
How to win the ovarian cancer stem cell battle: destroying the roots.如何打赢卵巢癌干细胞之战:斩草除根。
Cancer Drug Resist. 2020 Dec 22;3(4):1021-1033. doi: 10.20517/cdr.2020.93. eCollection 2020.
5
Effect of Gene Knockout on Drug Resistance in Paclitaxel and Topotecan Resistant Human Ovarian Cancer Cell Lines in 2D and 3D Model.基因敲除对紫杉醇和拓扑替康耐药的人卵巢癌细胞系在 2D 和 3D 模型中的耐药性的影响。
Int J Mol Sci. 2022 Mar 11;23(6):3036. doi: 10.3390/ijms23063036.
6
Cancer Stem Cells in Ovarian Cancer-A Source of Tumor Success and a Challenging Target for Novel Therapies.卵巢癌中的癌症干细胞——肿瘤成功的根源和新型治疗的挑战性靶点。
Int J Mol Sci. 2022 Feb 24;23(5):2496. doi: 10.3390/ijms23052496.
7
The Embryonic Key Pluripotent Factor NANOG Mediates Glioblastoma Cell Migration via the SDF1/CXCR4 Pathway.胚胎关键多能因子 NANOG 通过 SDF1/CXCR4 通路介导向神经胶质瘤细胞迁移。
Int J Mol Sci. 2021 Sep 30;22(19):10620. doi: 10.3390/ijms221910620.
8
Loss of Krüppel-like factor 9 facilitates stemness in ovarian cancer ascites-derived multicellular spheroids via Notch1/slug signaling.Krüppel 样因子 9 的缺失通过 Notch1/slug 信号通路促进卵巢癌腹水来源的多细胞球体的干性。
Cancer Sci. 2021 Oct;112(10):4220-4233. doi: 10.1111/cas.15100. Epub 2021 Aug 20.
9
Association of ALDH1A1-NEK-2 axis in cisplatin resistance in ovarian cancer cells.ALDH1A1-NEK-2轴与卵巢癌细胞顺铂耐药性的关联
Heliyon. 2020 Nov 12;6(11):e05442. doi: 10.1016/j.heliyon.2020.e05442. eCollection 2020 Nov.
10
Stem Cells in Ovarian Cancer and Potential Therapies.卵巢癌中的干细胞及潜在治疗方法。
Proc Stem Cell Res Oncog. 2020 May;8. Epub 2020 May 3.
Open Biol. 2013 Jan 8;3(1):120144. doi: 10.1098/rsob.120144.
4
Nanog signaling in cancer promotes stem-like phenotype and immune evasion.Nanog 信号在癌症中促进了类似干细胞的表型和免疫逃逸。
J Clin Invest. 2012 Nov;122(11):4077-93. doi: 10.1172/JCI64057. Epub 2012 Oct 24.
5
Cancer stem cells: current status and evolving complexities.癌症干细胞:现状与不断演变的复杂性。
Cell Stem Cell. 2012 Jun 14;10(6):717-728. doi: 10.1016/j.stem.2012.05.007.
6
Targeting cancer stem cells: a new therapy to cure cancer patients.靶向肿瘤干细胞:治愈癌症患者的新疗法。
Am J Cancer Res. 2012;2(3):340-56. Epub 2012 Apr 28.
7
Targeting the cancer initiating cell: the ultimate target for cancer therapy.针对癌症起始细胞:癌症治疗的终极目标。
Curr Pharm Des. 2012;18(13):1784-95. doi: 10.2174/138161212799859701.
8
Identification of a potential ovarian cancer stem cell gene expression profile from advanced stage papillary serous ovarian cancer.从晚期乳头状浆液性卵巢癌中鉴定出一种潜在的卵巢癌干细胞基因表达谱。
PLoS One. 2012;7(1):e29079. doi: 10.1371/journal.pone.0029079. Epub 2012 Jan 17.
9
Intratumoral heterogeneity in the self-renewal and tumorigenic differentiation of ovarian cancer.卵巢癌自我更新和致瘤分化的肿瘤内异质性。
Stem Cells. 2012 Mar;30(3):415-24. doi: 10.1002/stem.1029.
10
Long-term sphere culture cannot maintain a high ratio of cancer stem cells: a mathematical model and experiment.长期球体培养不能维持高比例的癌症干细胞:数学模型与实验。
PLoS One. 2011;6(11):e25518. doi: 10.1371/journal.pone.0025518. Epub 2011 Nov 16.